About Us
In the quest for improved health outcomes, standard approaches often fall short. E3 NexHealth takes a community centric and sustained strategic collaboration approach. Through in-depth situational analysis, needs assessment, and collaborative planning, we work alongside community leaders and the communities they serve to build customized roadmaps that transform health outcomes by leveraging and integrating resources from a broad set of partners.
We bridge the gap between community needs and available local and national resources, accelerating lasting change.
Mission
E3 NexHealth is committed to advancing health outcomes for everyone by actively engaging communities, forging impactful partnerships, and implementing innovative solutions. Our mission centers on addressing healthcare disparities, tackling social determinants of health, and advocating for inclusive healthcare as a fundamental human right.
Vision
To be a beacon of transformative change, E3 NexHealth envisions a future where health equity is not just a dream but a reality for all. Through unwavering commitment to community engagement, strategic partnerships, and innovative solutions, we aim to eradicate healthcare disparities and address social determinants of health. Our vision is rooted in the belief that inclusive healthcare is not just a goal but a basic human right, and we strive to lead the way in advocating for a healthier and more equitable world for all.
Anthonise Louis Fields, PhD
Dr. Anthonise Louis Fields serves as the chief executive officer and founder of E3 NexHealth, where she is leading the companies’ growth, directing strategy, securing significant partnerships, and advancing a portfolio of programs. With a strong scientific background punctuated with multiple publications and complemented by exceptional program leadership, strategic collaboration expertise honed over 20 years in the pharmaceutical industry [Merck & Co. (Merck), Johnson & Johnson (J&J), and Bristol Myers Squibb (BMS)], Dr. Fields has made significant contributions to advancing science and developing tailored approaches to optimize health outcomes for all communities.
At BMS, she served as an executive in Global Strategic Collaborations, forging research partnerships with expert US Academic Institutions across various therapeutic areas. Dr. Fields cultivated relationships with community pillars such as Essence and BlackDoctor.org, shattering misinformation and unlocking access to innovative medicines for cancer, cardiovascular disease, and even COVID-19. She has advocated for policies and initiatives aimed at closing the health equity gap by engaging the Congressional Black Caucus during their Hill Day events.
Before joining BMS, Dr. Fields excelled as Scientific Integration Lead at Janssen (J&J), advancing vaccine development and public health. At Merck, she drove the clinical development of diverse assets, overseeing a $2 billion budget, and achieving the prestigious Goldtrack Project Manager status.
Featured in Essence and Medium for her insights on health equity and diversity in science, Dr. Fields was honored with invitations to join the American Association of Cancer Research, and both BMS and Women of Color in Pharma (WOCIP) Speaker’s Bureau, underscoring her impact in cancer health equity.
Dr. Fields earned her PhD in Microbiology and Immunology from Temple School of Medicine and Bachelor’s in neuroscience (BBB) from the University of Pennsylvania, where she was a Howard Hughes and Penn Women’s Trustee scholar. She currently serves on the Board of the American Cancer Society (Philadelphia) and ArmorUp For Life. Dedicated to fostering diversity in scientific leadership, Dr. Fields founded the Gift of STEM, is an avid mentor, and served as an academic advisor and Board member of A Better Chance – Swarthmore.
E3 NexHealth Team and Partners
Meet our team, board, and partners.
Leadership Team
Board of Advisors
